| 26.4.2019 | Content and distribution of usnic acid enantiomers in three Icelandic lichen taxa | Aron Elvar Gylfason 1993- |
| 3.5.2016 | Correction of Dystrophin gene with Homology Directed Repair | Guðjón Reykdal Óskarsson 1991- |
| 3.5.2016 | CRISPR/Cas9 for the Correction of Mutated Dystrophin Gene | Thapa, Priyanka, 1988- |
| 30.4.2012 | Determination of half maximal inhibitory concentration (IC50) of several anticancer drugs for inhibiting CYP3A4 metabolism of midazolam | Íris Stella Heiðarsdóttir 1987- |
| 29.4.2011 | Determination of hydrating effects of moisturizing creams containing Icelandic plant extracts | Þórdís Þorvarðardóttir 1984- |
| 2.5.2017 | Developing Multifunctional Selenium and Iron Oxide Nanocomposites for Targeted Cancer Applications | Halla Laufey Hauksdóttir 1991- |
| 25.4.2022 | Development and optimization of gelatin/chitosan membranes for use in wound treatment | Theodór Árni Mathiesen 1997- |
| 3.5.2011 | Development of a LC-MS/MS Method for the Quantification of Cortisol and Cortisone | Arndís Sue Ching Löve 1985- |
| 12.4.2022 | Development of a modified release formulation for diclofenac sodium tablets | Ástþór Ingi Hannesson 1998-; Bjarni Björnsson 2000-; Elizabeth Ósk Anjie Löve 2000-; Eyþór Jón Þórsson 1998- |
| 20.4.2021 | Development of a patch for hand osteoarthritis | Ástrós Óskarsdóttir 1996- |
| 17.5.2013 | Development of a sample preparation method for the detection and identification of cholesterol in a Parkinson’s disease model utilizing MALDI-MSI | Ingólfur Birgisson 1988- |
| 28.4.2025 | Development of an absolute quantitation method of blood protein biomarkers for risk prediction of myocardial infarction events | Einar Magnús Hjaltason 2001- |
| 29.4.2019 | Development of an Erythromycin – Enzyme compatible formulation | Hólmfríður Gylfadóttir 1992- |
| 25.4.2022 | Development of an erythromycin-trypsin combination treatment for biofilm infections | Martin Janczewski 1996- |
| 25.4.2023 | Development of Aspirin Tablets with a Comparable Dissolution Profile to a Commercial Product | Una Þorsteinsdóttir 1999-; Jóhanna Lan 2001-; María Björk Pálsdóttir 2001- |
| 28.4.2020 | The development of buffering systems for the purification of biologics | Reynir Ágúst Guðbrandsson 1993- |
| 26.4.2023 | Development of caffeine tablets exhibiting similar dissolution profile to reference tablets | Magnús Gauti Úlfarsson 2000-; Einar Magnús Hjaltason 2001-; Urszula Bondarow 1998- |
| 28.4.2025 | Development of Caffeine Tablets with Dual Burst Release | Sigurbjörg Ásta Ólafsdóttir 1997-; Anna Vigdís Magnúsdóttir 2002-; Júlía Björk Geirsdóttir 2003-; María Sól Sigurðardóttir 2000- |
| 31.7.2013 | Development of cationic cyclodextrin polyrotaxane/hyaluronic acid complexes as nucleic acid carriers | Drobnjak, Tijana, 1987- |
| 21.4.2023 | Development of Gelatin-Curcumin Membranes for Wound Treatment : Optimization and property evaluation | Sævar Hrafn Jóhannsson 1999- |
Íslenska
